Skip to main content
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1968 Apr;25(2):152–154. doi: 10.1136/oem.25.2.152

Effect of 2,3-Dimercaptopropanol (BAL) on Urinary Excretion and Brain Content of Mercury

L Magos 1
PMCID: PMC1008728  PMID: 5647978

Abstract

2,3-Dimercaptopropanol (BAL) given to rats in doses used for the treatment of acute mercury chloride poisoning in man increases the excretion of mercury. The mercury content of the brain was unaffected by 2,3-dimercaptopropanol unless it was given a short time after the mercuric chloride, when there was a 24% increase. The relevance of these findings to therapy with BAL is discussed.

Full text

PDF
152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Longcope W. T., Luetscher J. A., Calkins E., Grob D., Bush S. W., Eisenberg H. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL. J Clin Invest. 1946 Jul;25(4):557–567. doi: 10.1172/JCI101738. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES